Market Place
Sourcing Support
Novartis, AbbVie & PhRMA secure 340B court win in West Virginia
19 Dec 2024 //
ENDPTS
Novartis, BioAge take on age-related diseases in $550M pact
19 Dec 2024 //
FIERCE BIOTECH
Pfizer’s Ibrance Improves Survival in New Breast Cancer Indication
12 Dec 2024 //
BIOSPACE
Monte Rosa Closes Global License Agreement With Novartis
11 Dec 2024 //
GLOBENEWSWIRE
Novartis Kisqali Nataled Data Show Durable Breast Cancer Benefits
10 Dec 2024 //
GLOBENEWSWIRE
Novartis Kisqali Natalee Data Show Durable Early Breast Cancer
10 Dec 2024 //
PR NEWSWIRE
Novartis` Scemblix Reinforces Superior Efficacy in Diagnosed CML
08 Dec 2024 //
GLOBENEWSWIRE
Novartis` latest bid to block MSN`s generic comes up short
06 Dec 2024 //
FIERCE PHARMA
PTC Therapeutics signs up to $2.9 B licensing deal with Novartis
03 Dec 2024 //
REUTERS
Novartis Kisqali® Approved for HR+/HER2- Early Breast Cancer
27 Nov 2024 //
GLOBENEWSWIRE
Shorla gains FDA nod for 1st oral version of Novartis` Gleevec
27 Nov 2024 //
BUSINESSWIRE
Novartis plots 139 layoffs in NJ, largely affecting field sales
26 Nov 2024 //
FIERCE PHARMA
Novartis Highlights Scemblix® and Kisqali® Data at ASH and SABCS
25 Nov 2024 //
GLOBENEWSWIRE
Novartis signs $1.1B deal for muscular dystrophy biotech
22 Nov 2024 //
PRESS RELEASE
Novartis Upgrades Mid-Term Guidance, Focuses On Pipeline
21 Nov 2024 //
GLOBENEWSWIRE
Novartis increases sales growth estimate through 2029
21 Nov 2024 //
FIERCE PHARMA
Novartis taps Vyriad’s viral vectors for in vivo T cell editing
20 Nov 2024 //
FIERCE BIOTECH
Vyriad Partners with Novartis to Develop In Vivo CAR-T Therapies
20 Nov 2024 //
PR NEWSWIRE
Novartis ranks first in 2024 Access to Medicine Index
19 Nov 2024 //
GLOBENEWSWIRE
Novartis, Ratio sign radiopharmaceutical pact of $745M
19 Nov 2024 //
FIERCE BIOTECH
Azurity scores FDA nod for new formulation of Novartis` Tasigna
16 Nov 2024 //
FIERCE PHARMA
Novartis pays Schrödinger $150M to form drug discovery pact
13 Nov 2024 //
PR NEWSWIRE
MediciNova Faces Monetary Damages from Sanofi-Novartis Patent
11 Nov 2024 //
GLOBENEWSWIRE
Novartis filed patent lawsuits in defense of radiopharma meds
04 Nov 2024 //
FIERCE PHARMA
Novartis CEO `very confident` on sales target, doesn`t fear patent cliff
04 Nov 2024 //
REUTERS
Novartis`s Biologic Ilaris Receives Suppl Approval in US
01 Nov 2024 //
FDA
Novartis` $2.9B MorphoSys bet stumbles as safety delays filing
30 Oct 2024 //
FIERCE BIOTECH
Novartis` Scemblix leaps into newly diagnosed CML
30 Oct 2024 //
FIERCE PHARMA
Novartis complies with FDA `flexibility` ask in Pluvicto filing
29 Oct 2024 //
FIERCE PHARMA
Novartis Explores Obesity Drugs While Focusing on Growth Areas
29 Oct 2024 //
REUTERS
Novartis Raises Yearly Outlook Despite Disappointing Pluvicto
29 Oct 2024 //
REUTERS
Novartis Reports Q3 Sales Growth and Raises FY 2024 Guidance
29 Oct 2024 //
GLOBENEWSWIRE
Novartis Scemblix® Approved for Newly Diagnosed CML
29 Oct 2024 //
GLOBENEWSWIRE
Novartis Inks $2.2B Molecular Glue Deal With Monte Rosa"
29 Oct 2024 //
REUTERS
Novartis, Apellis roll out rival datasets in rare kidney disease
28 Oct 2024 //
FIERCE PHARMA
Novartis’ Fabhalta® Maintains Results in C3G Phase III Trial
26 Oct 2024 //
GLOBENEWSWIRE
Novartis Ribociclib (Kisqali®) Receives NCCN Category 1 Status
24 Oct 2024 //
GLOBENEWSWIRE
Novartis ribociclib recognized as Category 1 preferred breast cancer treatment
24 Oct 2024 //
GLOBENEWSWIRE
Judge upholds MSN`s generic Entresto nod amid Novartis challenge
19 Oct 2024 //
FIERCE PHARMA
Novartis Gets Positive CHMP Opinion For Kisqali® In Breast Cancer
18 Oct 2024 //
GLOBENEWSWIRE
Novartis loses latest bid to block generic version of blockbuster heart drug
17 Oct 2024 //
REUTERS
Novartis pays Baiyu $70M, with $1.1B chaser, for cancer prospect
17 Oct 2024 //
FIERCE BIOTECH
PE firms queue up for Novartis` Indian arm
12 Oct 2024 //
ECONOMICTIMES
Swiss Authority Closes Novartis Probe Without Consequences
10 Oct 2024 //
REUTERS
Novartis`s Biologic Cosentyx (Secukinumab) Receives Approval in US
04 Oct 2024 //
FDA
Novartis inks $1B-plus biobucks deal with Flagship`s Generate
25 Sep 2024 //
BIOSPACE
Firefly Advances AI-Driven BNA™ Technology in Neuroscience
20 Sep 2024 //
GLOBENEWSWIRE
Novartis Gets Broad FDA Approval For Kisqali In Early Breast Cancer
18 Sep 2024 //
PR NEWSWIRE
PanTera Attracts $102.5M In Series A For Radiopharmaceutical Manufacturing
12 Sep 2024 //
ENDPTS
Relay Therapeutics` Combo Cuts Breast Cancer Progression In Early Study
10 Sep 2024 //
REUTERS
Despite trial scare, Travere`s IgAN drug wins full FDA approval
06 Sep 2024 //
FIERCE PHARMA
Novartis ignites new stage of Voyager pact with $15M capsid deal
05 Sep 2024 //
FIERCE BIOTECH
Novartis Begins Construction of New Radioligand Therapy Facilities in the US
05 Sep 2024 //
PR NEWSWIRE
Novartis brings blood cancer sculptures to Scotland, symptom awareness
02 Sep 2024 //
FIERCE PHARMA
Novartis` Leqvio Shows Promise in Lowering Cholesterol
29 Aug 2024 //
CONTRACT PHARMA
With phase 3 win, Novartis pads case for broader use of heart med Leqvio
28 Aug 2024 //
FIERCE PHARMA
Novartis To Spend $1B On New Biologics Formulations
28 Aug 2024 //
FIERCE PHARMA
Novartis Twice-Yearly Leqvio Demonstrated Clinically Meaningful LDL-C Lowering
28 Aug 2024 //
GLOBENEWSWIRE
Versant’s Jerel Davis on build-to-buy deals and pharma investment
26 Aug 2024 //
BIOPHARMADIVE
Siemens Healthineers To Acquire Novartis` European Radiodiagnostic Network
26 Aug 2024 //
FIERCE BIOTECH
